Cytogen cancer imaging diagnostic
Executive Summary
Firm received IND approval to conduct clinical trial of its in vivo cancer imaging diagnostic test. In the test, monoclonal antibodies specific to a targeted cancer are labeled with the radioisotope Indium and administered intravenously to patients. The first human testing of such a diagnostic is scheduled to begin immediately at Memorial Sloan-Kettering, Cytogen said.